Canadian Study of Arterial Inflammation in Patients With Diabetes and Vascular Events: EvaluatioN of Colchicine

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 115 participants.

Also called NCT04181996

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 115 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04181996
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04181996. Randomized; quadruple masking; primary purpose treatment. Start 2020-08-01 (actual); primary completion 2025-12-16 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Canadian Study of Arterial Inflammation in Patients With Diabetes and Vascular Events: EvaluatioN of Colchicine
Acronym
CADENCE
Condition
Cardiovascular Diseases
Condition
Atherosclerosis
Condition
Inflammation
Condition
Diabetes
Intervention (Drug)
Colchicine Oral Product
Intervention (Drug)
Placebo oral capsule
Lead sponsor
Ottawa Heart Institute Research Corporation (class: other)
Collaborator
Canadian Institutes of Health Research (CIHR) (class: other government)

Record details

Record id
cardio:ct-nct04181996
Content hash
cc896e37e98c1cc8976bdfe05b7fb616eea15ee1fbb2d7f69a546cf990d28ba2